Long-Term Follow-Up Gene Therapy Study for Achromatopsia CNGB3
Condition: Achromatopsia Intervention: Biological: AAV - CNGB3 Sponsors: MeiraGTx UK II Ltd; Syne Qua Non Limited; Emas Pharma Ltd. Recruiting - verified September 2017
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials